Do antimicrobial peptides and complement collaborate in the intestinal mucosa?

Frontiers in Immunology

Volumn 6, Issue JAN, 2015, Pages

  Kopp, Zoë A ^a   Jain, Umang ^a   Van Limbergen, Johan ^a   Stadnyk, Andrew W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Anaphylatoxin; Antimicrobial peptide; Cathelicidin; Colitis; Defensin; Intestine; Lectin pathway; Paneth cell

Indexed keywords

ADENOSINE PHOSPHATE; ALPHA DEFENSIN; ANAPHYLATOXIN; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COMPLEMENT; DECAY ACCELERATING FACTOR; INTESTINAL TREFOIL FACTOR; PANCREATITIS ASSOCIATED PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ADAPTIVE IMMUNITY; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; GRANULOMATOUS INFLAMMATION; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; INTESTINE MUCOSA; LAMINA PROPRIA; MICROBIAL COLONIZATION; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84926646935     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00017     Document Type: Review

References (76)

1. Cunliffe RN, Mahida YR. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J Leukoc Biol (2004) 75:49-58. doi:10.1189/jlb.0503249
2. Inagaki-Ohara K, Dewi FN, Hisaeda H, Smith AL, Jimi F, Miyahira M, et al. Intestinal intraepithelial lymphocytes sustain the epithelial barrier function against Eimeria vermiformis infection. Infect Immun (2006) 74:5292-301. doi:10.1128/IAI.02024-05
3. Ismail AS, Severson KM, Vaishnava S, Behrendt CL, Yu X, Benjamin JL, et al. Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc Natl Acad Sci U S A (2011) 108:8743-8. doi:10.1073/pnas.1019574108
4. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol (2014) 14:141-52. doi:10.1038/nri3608
5. Wenzel UA, Magnusson MK, Rydström A, Jonstrand C, Hengst J, Johansson MEV, et al. Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis. PLoS One (2014) 9:e100217. doi:10.1371/journal.pone.0100217
6. Andoh A, Kinoshita K, Rosenberg I, Podolsky DK. Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells. J Immunol (2001) 167:3887-93. doi:10.4049/jimmunol.167.7.3887
7. Kaiser V, Diamond G. Expression of mammalian defensin genes. J Leukoc Biol (2000) 68:779-84.
8. Clevers HC, Bevins CL. Paneth cells: maestros of the small intestinal crypts. Annu Rev Physiol (2013) 75:289-311. doi:10.1146/annurev-physiol-030212-183744
9. Chu H, Mazmanian SK. Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol (2013) 14:668-75. doi:10.1038/ni.2635
10. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science (2011) 334:255-8. doi:10.1126/science.1209791
11. Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol (2014) 14:667-85. doi:10.1038/nri3738
12. Fahlgren A, Hammarström S, Danielsson Å, Hammarström M-L. Beta-defensin-3 and-4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol (2004) 137:379-85. doi:10.1111/j.1365-2249.2004.02543.x
13. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol (1999) 163:6718-24.
14. Ménard S, Förster V, Lotz M, Gütle D, Duerr CU, Gallo RL, et al. Developmental switch of intestinal antimicrobial peptide expression. J Exp Med (2008) 205:183-93. doi:10.1084/jem.20071022
15. Ouellette A, Bevins CL. Paneth cell defensins and innate immunity of the small intestine. Inflamm Bowel Dis (2001) 7:43-50. doi:10.1097/00054725-200102000-00007
16. Wilson CL, Ouellette AJ, Stachell DP, Ayabe T, López-Boado YS, Stratman JL, et al. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science (1999) 286:113-7. doi:10.1126/science.286.5437.113
17. Collins HM, Morris TM, Watson SA. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix matalloproteinase. Br J Cancer (2001) 84:1664-70. doi:10.1054/bjoc.2001.1831
18. Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol (2002) 3:583-90. doi:10.1038/ni797
19. Wilson CL, Schmidt AP, Pirila E, Valcore EV, Ferri N, Sorsa T, et al. Differential processing of α-and β-defensin precursors by matrix metalloproteinase-7 (MMP-7). J Biol Chem (2009) 284:8301-11. doi:10.1074/jbc.M809744200
20. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol (2004) 22:181-215. doi:10.1146/annurev.immunol.22.012703.104603
21. Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med (2013) 5:1465-83. doi:10.1002/emmm.201201773
22. Frye M, Bargon J, Lembcke B, Wagner TOF, Gropp R. Differential expression of human α-and β-defensins mRNA in gastrointestinal epithelia. Eur J Clin Invest (2000) 30:695-701. doi:10.1046/j.1365-2362.2000.00696.x
23. Nata K, Liu Y, Xu L, Ikeda T, Akiyama T, Noguchi N, et al. Molecular cloning, expression and chromosomal localization of a novel human REG family gene, REG III. Gene (2004) 340:161-70. doi:10.1016/j.gene.2004.06.010
24. Matsumoto S, Konishi H, Maeda R, Kiryu-Seo S, Kiyama H. Expression analysis of the regenerating gene (Reg) family members Reg-IIIβ and Reg-IIIγ in the mouse during development. J Comp Neurol (2012) 520:479-94. doi:10.1002/cne.22705
25. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (2006) 313:1126-30. doi:10.1126/science.1127119
26. Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol (2012) 280:22-36. doi:10.1016/j.cellimm.2012.11.009
27. Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun (2002) 70:953-63. doi:10.1128/IAI.70.2.953-963.2002
28. Ogawa H, Fukushima K, Naito H, Funayama Y, Unno M, Takahashi K, et al. Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm Bowel Dis (2003) 9:162-70. doi:10.1097/00054725-200305000-00003
29. Cunliffe RN, Rose FRAJ, Keyte J, Abberley L, Chan WC, Mahida YR. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cell in the colon in inflammatory bowel disease. Gut (2001) 48:176-85. doi:10.1136/gut.48.2.176
30. Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Kallajoki M, Nevalainen TJ. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. Gut (1997) 40:95-101. doi:10.1136/gut.40.1.95
31. Shi J. Defensins and Paneth cells in inflammatory bowel disease. Inflamm Bowel Dis (2007) 13:1284-92. doi:10.1002/ibd.20197
32. Shanahan MT, Carroll IM, Grossniklaus E, White A, von Furstenberg RJ, Barner R, et al. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut (2014) 63:903-10. doi:10.1136/gutjnl-2012-304190
33. Fahlgren A, Hammarström S, Danielsson Å, Hammarström M-L. Increased expression of antimicrobial peptides and lysozyme in colonic cells of patients with ulcerative colitis. Clin Exp Immunol (2003) 131:90-101. doi:10.1046/j.1365-2249.2003.02035.x
34. Natividad JMM, Hayes CL, Motta J-P, Jury J, Galipeau HJ, Philip V, et al. Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950. Appl Environ Microbiol (2013) 79:7745-54. doi:10.1128/AEM.02470-13
35. Schauber J, Svanholm C, Termén S, Iffland K, Menzel T, Scheppach W, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut (2003) 52:735-41. doi:10.1136/gut.52.5.735
36. Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H, et al. Graft-versus host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood (2012) 120:223-31. doi:10.1182/blood-2011-12-401166
37. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nuñez G, et al. Nod-2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 307:731-4. doi:10.1126/science.1104911
38. Petnicki-Ocwieja T, Nrncir T, Liu Y-J, Biswas A, Hudcovic T, Tlaskalova-Hogenova H, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A (2009) 106:15813-8. doi:10.1073/pnas.0907722106
39. Biswas A, Liu Y-J, Hao L, Mizoguchi A, Salzman NH, Bevins CL, et al. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A (2010) 107:14739-44. doi:10.1073/pnas.1003363107
40. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature (2003) 422:522-6. doi:10.1038/nature01520
41. Koon HW, Shih DQ, Chen J, Bakirtzi K, Hing TC, Law I, et al. Cathelicidin signaling via the toll-like receptor protects against colitis in mice. Gastroenterology (2011) 141:1852-63. doi:10.1053/j.gastro.2011.06.079
42. Tai E, Wu W, Wang X, Wong HPS, Yu L, Li ZJ, et al. Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp-/-mice. Gene Ther (2013) 20:187-93. doi:10.1038/gt.2012.22
43. Chromek M, Arvidsson I, Karpman D. The antimicrobial peptide cathelicidin protects mice from Escherichia coli 0157:H7-mediated disease. PLoS One (2012) 7:e46476. doi:10.1371/journal.pone.0046476
44. Loonen LMP, Stolte EH, Jaklofsky MTJ, Meijerink M, Dekker J, van Baarlen P, et al. REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol (2014) 7:939-47. doi:10.1038/mi.2013.109
45. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 11:785-97. doi:10.1038/ni.1923
46. Kemper C, Atkinson JP, Hourcade DE. Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol (2010) 28:131-55. doi:10.1146/annurev-immunol-030409-101250
47. Lesher AM, Nilsson B, Song WC. Properdin in complement activation and tissue injury. Mol Immunol (2013) 56:191-8. doi:10.1016/j.molimm.2013.06.002
48. Spitzer D, Mitchell LM, Atkinson JP, Hourcade DE. Properdin can initiate complement activation by binding specific target surfacs and providing a platform for de novo convertase assembly. J Immunol (2010) 179:2600-8. doi:10.4049/jimmunol.179.4.2600
49. Selander B, Martensson U, Weintraub A, Holmstrom E, Matsushita M, Theil S, et al. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest (2006) 116:1425-34. doi:10.1172/JCI25982
50. Tateishi K, Matsushita M. Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway. Microbiol Immunol (2011) 55:817-21. doi:10.1111/j.1348-0421.2011.00378.x
51. Matsushita M, Fujita T. Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent activation. Immunobiology (1995) 194:443-8. doi:10.1016/S0171-2985(11)80110-5
52. Takahashi M, Ishida Y, Iwaki D, Kanno K, Suzuki T, Endo Y, et al. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J Exp Med (2010) 207:29-37. doi:10.1084/jem.20090633
53. Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, Gebhard F, et al. Interaction between the coagulation and complement system. Adv Exp Med Biol (2008) 632:71-9.
54. Harboe M, Mollnes TE. The alternative complement pathway revisited. J Cell Mol Med (2008) 12:1074-84. doi:10.1111/j.1582-4934.2008.00350.x
55. Lutz HU, Jelezarova E. Complement amplification revisited. Mol Immunol (2006) 43:2-12. doi:10.1016/j.molimm.2005.06.020
56. Halstensen TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology (1990) 98:1264-71.
57. Halstensen TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis. Gut (1992) 33:902-8. doi:10.1136/gut.33.7.902
58. Ahrenstedt O, Knutson L, Nilsson B, Nilsson-Ekdahl K, Odlind B, Hallgren R. Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med (1990) 322:1345-9. doi:10.1056/NEJM199005103221903
59. Riordan SM, McIver CJ, Wakefield D, Andreopoulos PC, Duncombe VM, Bolin TD, et al. Local and systemic complement activity in small intestinal bacterial overgrowth. Dig Dis Sci (1997) 42:1128-36. doi:10.1023/A:1018821200354
60. Andoh A, Fujiyama Y, Sumiyoshi K, Bamba T. Local secretion of complement C3 in the exocrine pancreas: ductal epithelial cells as a possible biosynthetic site. Gastroenterology (1996) 110:1919-25. doi:10.1053/gast.1996.v110.pm8964419
61. Laufer J, Oren R, Goldberg I, Horowitz A, Kopolovic J, Chowers Y, et al. Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease. Clin Exp Immunol (2000) 120:30-7. doi:10.1046/j.1365-2249.2000.01168.x
62. Sugihara T, Kobori A, Imaeda H, Tsujikawa T, Amagase K, Takeuchi K, et al. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin Exp Immunol (2010) 160:386-93. doi:10.1111/j.1365-2249.2010.04093.x
63. Ostvik AE, Granlund AV, Gustafsson BI, Torp SH, Espevik T, Mollnes TE, et al. Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease. Inflamm Bowel Dis (2014) 20:995-1003. doi:10.1097/MIB.0000000000000035
64. Müller S, Schaffer T, Flogerzi B, Seibold-Schmid B, Schnider J, Takahashi K, et al. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens. Gut (2010) 59:1493-500. doi:10.1136/gut.2010.208348
65. Bernet-Camard MF, Coconnier MH, Hudault S, Servin AL. Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines. Gut (1996) 38:248-53. doi:10.1136/gut.38.2.248
66. Andoh A, Fujiyama Y, Bamba T, Hosoda S. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol (1993) 151:4239-47.
67. Wirthmueller U, Dewald B, Thelen M, Schäfer MKH, Stover C, Whaley K, et al. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol (1997) 158:4444-51.
68. Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med (1987) 165:848-64. doi:10.1084/jem.165.3.848
69. Cao Q, McIsaac SM, Stadnyk AW. Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway. Am J Physiol Cell Physiol (2012) 302:C1731-40. doi:10.1152/ajpcell.00213.2011
70. Chehoud C, Rafail S, Tyldsley AS, Seykora JT, Lambris JD, Grice EA. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc Natl Acad Sci U S A (2014) 110:15061-6. doi:10.1073/pnas.1307855110
71. Nordahl EA, Rydengård V, Nyberg P, Nitsche DP, Mörgelin M, Mörgelin M, et al. Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A (2004) 101:16879-84. doi:10.1073/pnas.0406678101
72. Sonesson A, Ringstad L, Nordahl EA, Malmsten M, Mörgelin M, Schmidtchen A. Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim Biophys Acta (2007) 1768:346-53. doi:10.1016/j.bbamem.2006.10.017
73. Lisewski MK, Kolev M, Le Friec G, Leung M, Bertram PG, Fara AF, et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity (2013) 39:1143-57. doi:10.1016/j.immuni.2013.10.018
74. Leffler J, Martin M, Gullstrand B, Tydén H, Lood C, Treudsson L, et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol (2012) 188:3522-31. doi:10.4049/jimmunol.1102404
75. Bhat S, Song Y-H, Lawyer C, Milner SM. Modulation of the complement system by human β-defensin 2. J Burns Wounds (2006) 5:e10.
76. Liu Y, Liu Y, Zhang X, Wang J, Li Z, Pang X, et al. Complement-related proteins control the Flavivirus infection of Aedes aegypti by inducing antimicrobial peptides. PLoS Pathog (2014) 10:e1004027. doi:10.1371/journal.ppat.1004027